Fairvalue-Calculator Fairvalue-Calculator

ChenGuang Biotech Group (300138) Fair Value & Analysis

Consumer Defensive · CN · Market cap 4.8B CNY

Price¥9.67
Fair Value¥12.80
Upside+32.4%
Quality94/100
Evidence: High Range ¥9.60 – ¥16.00

Analysis

ChenGuang Biotech Group (300138) currently trades at ¥9.67, while our model-based Fair Value estimate is ¥12.80 — implying the stock looks roughly 32.4% undervalued today. We read business quality at 94/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oleoresin, fennel oleoresin, celery seed essential oil, litsea cubeba oil, garlic essential oil cinnamon and star anise essential oil; lutein, lycopene, grape seed extract, curcumin, and milk thistle extract; stevia, monk fruit, wheat germ, silybum marianum and grape seed oil, walnut oil, safflower seed oil, flaxseed oil, and animal feed, including Lutein, paprika, crude extract of turmeric, marigold flavonoids. Its products are used in food and beverage, condiment, pharmaceutical, health product, nutritional supplement, cosmetic, and feed additive industries. The company exports its products to…

Open the full interactive analysis →

Similar stocks

Archer-Daniels-Midland Company (ADM) -53% MHP SE (MHPC) -88% Muyuan Foods Group (002714) +40% Bunge Global SA (BG) -31% Tyson Foods, Inc (TSN) -17% Wens Foodstuff Group (300498) -3%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.